Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

Bibliographic Details
Main Authors:	C. Meads, C. Salas, T. Roberts, D. Moore, A. Fry-Smith, C. Hyde
Format:	Article
Language:	English
Published:	NIHR Journals Library 2003-01-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta7090

Similar Items

Comparison of lucentis and photodynamic therapy in the treatment of wet age-related macular degeneration
by: Xin-Dan Wang, et al.
Published: (2014-03-01)

PHOTODYNAMIC THERAPY OF MACULAR DEGENERATION
by: Davorin Sevšek, et al.
Published: (2004-05-01)

Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand
by: Piyameth Dilokthornsakul, et al.
Published: (2014-02-01)

Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
by: Ekta Rishi, et al.
Published: (2016-01-01)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
by: Adinoyi O. Garba, et al.
Published: (2010-12-01)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
by: Adinoyi O. Garba, et al.
Published: (2010-01-01)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
by: Chaikin L, et al.
Published: (2015-12-01)

Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
by: Hüseyin Dündar, et al.
Published: (2014-10-01)

Future Therapies of Wet Age-Related Macular Degeneration
by: Makoto Ishikawa, et al.
Published: (2015-01-01)

Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
by: Stewart MW
Published: (2012-07-01)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
by: Dervenis N, et al.
Published: (2016-06-01)

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.
by: BC Reeves, et al.
Published: (2012-02-01)

On the efficiency of treatment of wet age-related macular degeneration with Lucentis
by: E. M. Kasimov, et al.
Published: (2018-10-01)

Research progress of pharmacogenetics with wet age-related macular degeneration
by: Si-Meng Zheng, et al.
Published: (2020-01-01)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
by: Alfredo García-Layana, et al.
Published: (2015-01-01)

Recent advances in treatment of wet age-related macular degeneration
by: Ming Li, et al.
Published: (2015-02-01)

Effect of Lucentis combined with photodynamic therapy on visual performance and sensitivity as well as serum VEGF levels in patients with wet age-related macular degeneration
by: Miao He, et al.
Published: (2016-09-01)

NORMAL FLUENCE PHOTODYNAMIC THERAPY ASSOCIATED WITH LAMELLAR MACULAR HOLES IN EXUDATIVE AGE RELATED MACULAR DEGENERATION
by: Alvaro Rodriguez, et al.
Published: (2014-09-01)

Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
by: Agnieszka Nowosielska
Published: (2019-10-01)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
by: Dervenis N, et al.
Published: (2016-12-01)

Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration
by: Ayhan Ozyurt, et al.
Published: (2017-01-01)

OCTA in evaluating therapeutic effect of wet age-related macular degeneration
by: Liang Wang, et al.
Published: (2020-06-01)

Clinical efficacy of Ranibizumab in the treatment of wet age-related macular degeneration
by: Ling-Jun Wei, et al.
Published: (2017-12-01)

Effect of conbercept or ranibizumab in the treatment of wet age-related macular degeneration
by: Dawei Zhang, et al.
Published: (2019-01-01)

Study progress of CCR3 in wet age-related macular degeneration
by: Xian-Wei Wu, et al.
Published: (2014-03-01)

Research progress on risk factors of wet age-related macular degeneration
by: Meng Wang, et al.
Published: (2018-09-01)

Research progress in gene therapy for wet age-related macular degeneration
by: Yi Zhang, et al.
Published: (2020-03-01)

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
by: Neffendorf JE, et al.
Published: (2015-09-01)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
by: Keles S, et al.
Published: (2014-08-01)

Curative effect of different drugs in treatment of senile wet macular degeneration
by: Zhi-Qin Zhang, et al.
Published: (2017-06-01)

Wide-Field Fluorescein Angiography in Wet Age-Related Macular Degeneration
by: Savitha Madhusudhan, et al.
Published: (2014-01-01)

Efficiency of Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
by: Didem sahin, et al.
Published: (2015-12-01)

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration
by: J Karnon, et al.
Published: (2008-06-01)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
by: Jos&eacute; M&ordf; Ruiz-Moreno, et al.
Published: (2008-03-01)

The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea.
by: Ho Ra, et al.
Published: (2018-01-01)

Patients&rsquo; knowledge and perspectives on wet age-related macular degeneration and its treatment
by: Sushma Kandula, et al.
Published: (2010-04-01)

Long-term results after limited macular translocation surgery for wet age-related macular degeneration.
by: Hisaaki Oshima, et al.
Published: (2017-01-01)

Changes of retinal structure in macular region after treatment with Conbercept for wet age-related macular degeneration
by: Ping-Ping Liu, et al.
Published: (2020-02-01)

A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal
by: Rufino Silva, et al.
Published: (2017-06-01)

Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
by: Kimberley Delaunay, et al.
Published: (2021-07-01)